As reported by Business Insider in late August, Dexcom announced that it had acquired TypeZero Technologies, Inc. TypeZero’s offering includes the inControl diabetes management system, designed to provide personalized diabetes management solutions including technology to automatically adjust and regulate insulin delivery.
Dexcom, TypeZero and the University of Virginia have had a longstanding relationship working towards developing important technologies for diabetes management, including inControl for integration with both automated insulin delivery (AID, in other words insulin pumps) and smart insulin pens.
Steve Pacelli, Dexcom’s Executive Vice President of Strategy & Corporate Development, commented, “TypeZero is a great fit for Dexcom as we look to deliver a growing set of tools to both our insulin delivery partners and our customers. Combined with best-in-class CGM technology, we believe TypeZero’s technology and strong team will accelerate our efforts to further differentiate Dexcom’s portfolio.”
Chad Rogers, TypeZero’s CEO, added, “For the last several years, our company has been committed to creating diabetes management products that simplify the life of a person with diabetes. As part of Dexcom, we will continue to embrace the mission to empower people with diabetes through innovation.”
Dexcom expects to support the first commercial launch of an AID system using the inControl algorithm in 2019.
News items and features like this appear in the Desang Diabetes Magazine, our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it’s free, and you can easily unsubscribe should you wish to).
